BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 32579979)

  • 1. Effect of 5-HT
    Wankhar W; Syiem D; Pakyntein CL; Thabah D; Sunn SE
    Behav Brain Res; 2020 Sep; 393():112780. PubMed ID: 32579979
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A short history of the 5-HT
    Palacios JM; Pazos A; Hoyer D
    Psychopharmacology (Berl); 2017 May; 234(9-10):1395-1418. PubMed ID: 28265714
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Postnatal fluoxetine-evoked anxiety is prevented by concomitant 5-HT2A/C receptor blockade and mimicked by postnatal 5-HT2A/C receptor stimulation.
    Sarkar A; Chachra P; Vaidya VA
    Biol Psychiatry; 2014 Dec; 76(11):858-68. PubMed ID: 24315410
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of 5-HT2C receptors of the dorsal hippocampus in the modulation of anxiety- and panic-related defensive responses in rats.
    Sant'Ana AB; Vilela-Costa HH; Vicente MA; Hernandes PM; de Andrade TGCS; Zangrossi H
    Neuropharmacology; 2019 Apr; 148():311-319. PubMed ID: 30685402
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Altered 5-HT2C receptor agonist-induced responses and 5-HT2C receptor RNA editing in the amygdala of serotonin transporter knockout mice.
    Moya PR; Fox MA; Jensen CL; Laporte JL; French HT; Wendland JR; Murphy DL
    BMC Pharmacol; 2011 Apr; 11():3. PubMed ID: 21473759
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incubation of cocaine cue reactivity associates with neuroadaptations in the cortical serotonin (5-HT) 5-HT2C receptor (5-HT2CR) system.
    Swinford-Jackson SE; Anastasio NC; Fox RG; Stutz SJ; Cunningham KA
    Neuroscience; 2016 Jun; 324():50-61. PubMed ID: 26926963
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serotonin-2C receptors in the basolateral nucleus of the amygdala mediate the anxiogenic effect of acute imipramine and fluoxetine administration.
    Vicente MA; Zangrossi H
    Int J Neuropsychopharmacol; 2012 Apr; 15(3):389-400. PubMed ID: 21733232
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Implication of the 5-HT2A and 5-HT2C (but not 5HT1A) receptors located within the periaqueductal gray in the elevated plus-maze test-retest paradigm in mice.
    Gomes KS; Nunes-De-Souza RL
    Prog Neuropsychopharmacol Biol Psychiatry; 2009 Oct; 33(7):1261-9. PubMed ID: 19625008
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting the 5-HT2C Receptor in Biological Context and the Current State of 5-HT2C Receptor Ligand Development.
    Wold EA; Wild CT; Cunningham KA; Zhou J
    Curr Top Med Chem; 2019; 19(16):1381-1398. PubMed ID: 31288724
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Involvement of 5-HT2C and 5-HT1A receptors of the basolateral nucleus of the amygdala in the anxiolytic effect of chronic antidepressant treatment.
    Vicente MA; Zangrossi H
    Neuropharmacology; 2014 Apr; 79():127-35. PubMed ID: 24275045
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 5HT3 receptor antagonist (ondansetron) reverses depressive behavior evoked by chronic unpredictable stress in mice: modulation of hypothalamic-pituitary-adrenocortical and brain serotonergic system.
    Gupta D; Radhakrishnan M; Kurhe Y
    Pharmacol Biochem Behav; 2014 Sep; 124():129-36. PubMed ID: 24909071
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of 5-HT(2C) mediated mechanisms involved in urethral sphincter reflexes in a guinea-pig model of urethral function.
    Conlon K; Miner W; McCleary S; McMurray G
    BJU Int; 2012 Jul; 110(2 Pt 2):E113-7. PubMed ID: 22192599
    [TBL] [Abstract][Full Text] [Related]  

  • 13. S32006, a novel 5-HT2C receptor antagonist displaying broad-based antidepressant and anxiolytic properties in rodent models.
    Dekeyne A; Mannoury la Cour C; Gobert A; Brocco M; Lejeune F; Serres F; Sharp T; Daszuta A; Soumier A; Papp M; Rivet JM; Flik G; Cremers TI; Muller O; Lavielle G; Millan MJ
    Psychopharmacology (Berl); 2008 Sep; 199(4):549-68. PubMed ID: 18523738
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serotonin modulates fast-spiking interneuron and synchronous activity in the rat prefrontal cortex through 5-HT1A and 5-HT2A receptors.
    Puig MV; Watakabe A; Ushimaru M; Yamamori T; Kawaguchi Y
    J Neurosci; 2010 Feb; 30(6):2211-22. PubMed ID: 20147548
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Facilitation of 5-HT(2A/2C)-mediated neurotransmission in the ventromedial hypothalamic nucleus decreases anxiety in the elevated T-maze.
    da Silva ES; Poltronieri SC; Nascimento JO; Zangrossi H; Viana MB
    Behav Brain Res; 2011 Jan; 216(2):692-8. PubMed ID: 20883726
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Orbitofrontal cortex 5-HT2A receptor mediates chronic stress-induced depressive-like behaviors and alterations of spine density and Kalirin7.
    Xu C; Ma XM; Chen HB; Zhou MH; Qiao H; An SC
    Neuropharmacology; 2016 Oct; 109():7-17. PubMed ID: 26921771
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Different roles of distinct serotonergic pathways in anxiety-like behavior, antidepressant-like, and anti-impulsive effects.
    Ohmura Y; Tsutsui-Kimura I; Sasamori H; Nebuka M; Nishitani N; Tanaka KF; Yamanaka A; Yoshioka M
    Neuropharmacology; 2020 May; 167():107703. PubMed ID: 31299228
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Involvement of dorsal raphe nucleus and dorsal periaqueductal gray 5-HT receptors in the modulation of mouse defensive behaviors.
    Pobbe RL; Zangrossi H; Blanchard DC; Blanchard RJ
    Eur Neuropsychopharmacol; 2011 Apr; 21(4):306-15. PubMed ID: 20570114
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Involvement of some subtypes of 5-HT2-receptors in affective behavior in female rats].
    Fedotova IuO; Ordian NE; Frolova HO; Soboliev VI
    Fiziol Zh (1994); 2012; 58(6):75-80. PubMed ID: 23530416
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anxiety during alcohol withdrawal involves 5-HT2C receptors and M-channels in the lateral habenula.
    Fu R; Mei Q; Shiwalkar N; Zuo W; Zhang H; Gregor D; Patel S; Ye JH
    Neuropharmacology; 2020 Feb; 163():107863. PubMed ID: 31778691
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.